NIRLUS
Non-Invasive Blood-Sugar Measurement
Innovative Non-invasive Technologies
Research and Development Corporation
NIRLUS Engineering AG is a venture funded Research and Development corporation, established in 2006. Since inception, the technology innovator has pursued the development of cutting edge technologies for non-invasive analysis of chemical compositions of human blood.
The corporation holds numerous international patents in this field and has developed several prototypes.
Breakthrough Medical Innovations
In its pursuit to provide medical innovations that will improve the lives of people globally, NIRLUS has strategically targeted the 2 billion USD glucose monitoring market for diabetics.
The company has succeeded with the development of a revolutionary device by using near-infrared laser-light and ultrasound in combination. This approach results in a completely unique signal that, when analyzed, gives relevant information about consistence of patients’ blood.
The result is, that patients will improve their health and wellbeing by being able to monitor blood sugar levels more frequently, thus offering a more favorable outcome and potentially longer lifespan.
Breakthrough Medical Innovations
In its pursuit to provide medical innovations that will improve the lives of people globally, NIRLUS has strategically targeted the 2 billion USD glucose monitoring market for diabetics.
The company has succeeded with the development of a revolutionary device by using near-infrared laser-light and ultrasound in combination. This approach results in a completely unique signal that, when analyzed, gives relevant information about consistence of patients’ blood.
The result is, that patients will improve their health and wellbeing by being able to monitor blood sugar levels more frequently, thus offering a more favorable outcome and potentially longer lifespan.
Our Non- Invasive Blood Monitoring Device
The NIRLUS Device is a breakthrough technological innovation, providing real-time non-invasive blood monitoring and the analysis of blood sugar levels by using near-infrared light and ultrasound. This device is a life-enhancing medical application that will radically change the lives of the millions of patients currently struggling with the management of diabetes, and the expanding global population yet to be afflicted.
Patients will improve their health and wellbeing by being able to monitor blood sugar levels more frequently, thus offering a more favorable outcome and potentially longer lifespan.
Consistency
In 2005 NIRLUS won the first 1st place in the “Entrepreneuers’ Innovation Summer School (EISS)” competition, an award created by the Christian- Albrechts-University of Kiel and the Innovation Fund Schleswig-Holstein.
Over the course of the last decade, the corporation has established and registered numerous of national and international patents to protect its proprietary research and technology.
Consistency
In 2005 NIRLUS won the first 1st place in the “Entrepreneuers’ Innovation Summer School (EISS)” competition, an award created by the Christian- Albrechts-University of Kiel and the Innovation Fund Schleswig-Holstein.
Over the course of the last decade, the corporation has established and registered numerous of national and international patents to protect its proprietary research and technology.